Hangzhou Alltest Biotech Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 754.68 million compared to CNY 3,388.57 million a year ago. Net income was CNY 180.05 million compared to CNY 1,184.48 million a year ago.

Basic earnings per share from continuing operations was CNY 2.27 compared to CNY 14.94 a year ago.